Technology area: Biotechnology & Pharmaceuticals
6 pending office actions • 5 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Wageningen Universiteit has 6 pending office actions in Biotechnology & Pharmaceuticals. The matters are assigned to 6 distinct examiners and 5 distinct art units, indicating broad examiner distribution with some shared technical-unit context.
GOUGH, TIFFANY MAUREEN is the busiest examiner, with 1 pending matter. The profile favors separate examiner analysis for each matter, while the 5 art units provide a basis for coordinating technical themes and prior-art review where assignments overlap.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (17%) |
| §103 only | 1 (17%) |
| §112 only | 1 (17%) |
| Multi-statute (no §101) | 3 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GOUGH, TIFFANY MAUREEN | 1 | 31.7% | +46.5% |
| ROTONDI, CONNOR JON | 1 | 40.0% | +40.0% |
| HOLLAND, PAUL J | 1 | 57.3% | +64.7% |
| VANHORN, ABIGAIL LOUISE | 1 | 46.8% | +22.7% |
| REGA, KYLE THOMAS | 1 | 63.0% | +41.7% |
| BUCHANAN, BAILEY CHEYENNE | 1 | 42.9% | +57.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19224021 | USE OF AKKERMANSIA FOR TREATING METABOLIC DISORDERS | GOUGH, TIFFANY MAUREEN | — |
| 18704937 | Removal of micropollutants from water and installation for use therein | ROTONDI, CONNOR JON | — |
| 18282782 | METHODS FOR RECOMBINANT PROTEIN EXPRESSION IN EUKARYOTIC CELLS | HOLLAND, PAUL J | — |
| 18273501 | CRISPR-ASSOCIATED BASED-EDITING OF THE COMPLEMENTARY STRAND | VANHORN, ABIGAIL LOUISE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19224021 | USE OF AKKERMANSIA FOR TREATING METABOLIC DISORDERS | GOUGH, TIFFANY MAUREEN | — |
| 18704937 | Removal of micropollutants from water and installation for use therein | ROTONDI, CONNOR JON | — |
| 18282782 | METHODS FOR RECOMBINANT PROTEIN EXPRESSION IN EUKARYOTIC CELLS | HOLLAND, PAUL J | — |
| 18273501 | CRISPR-ASSOCIATED BASED-EDITING OF THE COMPLEMENTARY STRAND | VANHORN, ABIGAIL LOUISE | — |
| 18248080 | UNIVERSAL RIBOSWITCH FOR INDUCIBLE GENE EXPRESSION | REGA, KYLE THOMAS | — |
| 17619773 | Type III CRISPR/Cas-based Diagnostics | BUCHANAN, BAILEY CHEYENNE | — |
| Art Unit | Apps |
|---|---|
| 1636 | 2 |
| 1651 | 1 |
| 1778 | 1 |
| 1656 | 1 |
| 1682 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19224021 | USE OF AKKERMANSIA FOR TREATING METABOLIC DISORDERS | GOUGH, TIFFANY MAUREEN | 1651 | §101DP | Final Rejection | — | Pending | May 30, 2025 |
| 18704937 | Removal of micropollutants from water and installation for use therein | ROTONDI, CONNOR JON | 1778 | §103§112 | Non-Final OA | — | Pending | Apr 26, 2024 |
| 18282782 | METHODS FOR RECOMBINANT PROTEIN EXPRESSION IN EUKARYOTIC CELLS | HOLLAND, PAUL J | 1656 | §102§103§112 | Non-Final OA | — | Pending | Sep 18, 2023 |
| 18273501 | CRISPR-ASSOCIATED BASED-EDITING OF THE COMPLEMENTARY STRAND | VANHORN, ABIGAIL LOUISE | 1636 | §103§112 | Final Rejection | — | Pending | Jul 20, 2023 |
| 18248080 | UNIVERSAL RIBOSWITCH FOR INDUCIBLE GENE EXPRESSION | REGA, KYLE THOMAS | 1636 | §112 | Non-Final OA | — | Pending | Apr 06, 2023 |
| 17619773 | Type III CRISPR/Cas-based Diagnostics | BUCHANAN, BAILEY CHEYENNE | 1682 | §103 | Non-Final OA | — | Pending | Dec 16, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialWageningen Universiteit has 6 pending office actions as of October 2026, spread across 5 art units and 6 examiners.
Tiffany Maureen Gough has the most, with 1 of Wageningen Universiteit's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
